Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Vantive In Play

<< Previous

Bullboard Posts

Next >>

Comment by mercedesmanon Mar 05, 2024 9:52pm

129 Views

Post# 35917154

RE:RE:RE:RE:Vantive In Play

Thx Mac

Yes either the Vantive spin-off or the non-competitive divisional sell-off, will raise capital for two purposes :

1. debt reduction
2. take-overs of some higher margin businesses ( like say, idunno the NA rights to PMX)

If the sell-off becomes a more lucrative option than the spin-off option, then they will go for that and then there will be that much more money for objective #2

I'm pretty sure that this idea didnt just occur to Baxter in the 2 weeks since recommitting to Spectral and locking up the rights for longer.

MM

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China